BRAF and adenoma: For example, the additional driver mutation could be the mutation activating the KRAS/BRAF pathway in a small colorectal adenoma, associated with the transformation from small to large adenoma, or the mutation that transforms benign adenoma into infiltrating carcinoma (Jones et al. 2008a).